Lina Liu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Oxidative Stress

Top Venues

Blood cancer discovery

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Vujovic, Laura P M H de Rooij, Ava Keyvani Chahi, He Tian Tony Chen, Brian A Yee, Sampath Kumar Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E Dick, Mark D Minden, Daniel Schramek, Gene W Yeo, Kristin J Hope
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood cancer discovery (2023)
Ana Vujovic, Laura P M H de Rooij, Ava Keyvani Chahi, He Tian Tony Chen, Brian A Yee, Sampath Kumar Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E Dick, Mark D Minden, Daniel Schramek, Gene W Yeo, Kristin J Hope
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood cancer discovery (2023)
Shanshan Pei, Ian T Shelton, Austin E Gillen, Brett M Stevens, Maura Gasparetto, Yanan Wang, Lina Liu, Jun Liu, Tonya M Brunetti, Krysta Engel, Sarah Staggs, William Showers, Anagha Inguva Sheth, Maria L Amaya, Mohammad Minhajuddin, Amanda C Winters, Sweta B Patel, Hunter Tolison, Anna E Krug, Tracy N Young, Jeffrey Schowinsky, Christine M McMahon, Clayton A Smith, Daniel A Pollyea, Craig T Jordan
A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer discovery (2023)
Lina Liu, Ana Vujovic, Nandan P Deshpande, Shashank Sathe, Govardhan Anande, He Tian Tony Chen, Joshua Xu, Mark D Minden, Gene W Yeo, Ashwin Unnikrishnan, Kristin J Hope, Yu Lu
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors. Nature communications 13 (1) (2022)